IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

MARFELLA, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.690
EU - Europa 1.388
AS - Asia 580
SA - Sud America 208
AF - Africa 113
OC - Oceania 1
Totale 3.980
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.628
RU - Federazione Russa 1.112
SG - Singapore 244
BR - Brasile 162
CN - Cina 104
CI - Costa d'Avorio 96
VN - Vietnam 77
HK - Hong Kong 64
IT - Italia 45
DE - Germania 41
GB - Regno Unito 34
CA - Canada 32
IE - Irlanda 25
MX - Messico 24
FI - Finlandia 20
PL - Polonia 19
ES - Italia 18
IN - India 16
AR - Argentina 15
BD - Bangladesh 14
AT - Austria 13
JP - Giappone 13
NL - Olanda 13
UA - Ucraina 12
ZA - Sudafrica 11
CZ - Repubblica Ceca 10
ID - Indonesia 10
EC - Ecuador 9
CO - Colombia 8
LT - Lituania 8
IQ - Iraq 7
TR - Turchia 6
SE - Svezia 5
FR - Francia 4
VE - Venezuela 4
PE - Perù 3
PT - Portogallo 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BO - Bolivia 2
CL - Cile 2
EG - Egitto 2
HN - Honduras 2
MY - Malesia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 3.980
Salva come PNG Salva come JPEG
Città #
Dallas 1.004
Moscow 354
Singapore 141
Ashburn 105
Abidjan 96
Beijing 78
Hong Kong 63
Los Angeles 43
Ho Chi Minh City 34
New York 34
The Dalles 31
Boardman 27
Dublin 25
Warsaw 18
Denver 17
Hanoi 17
São Paulo 17
Munich 16
Tokyo 13
Amsterdam 12
Brooklyn 12
Montreal 12
London 11
Chennai 10
Helsinki 10
Jacksonville 10
Nuremberg 10
Poplar 10
Chicago 9
Santa Clara 9
Brno 8
Columbus 8
Mexico City 8
Phoenix 8
San Francisco 8
Terzigno 8
Atlanta 7
Chandler 7
Falkenstein 7
Querétaro 7
Boston 6
Córdoba 6
Houston 6
Johannesburg 6
Rio de Janeiro 6
Acerra 5
Ankara 5
Frankfurt am Main 5
Lappeenranta 5
Manchester 5
Mumbai 5
Orem 5
Toronto 5
Turku 5
Vienna 5
Assago 4
Charlotte 4
Guarulhos 4
Ottawa 4
Stockholm 4
Baie-D'Urfé 3
Curitiba 3
Guayaquil 3
Haiphong 3
Lima 3
Providence 3
Rome 3
Secaucus 3
Tashkent 3
Vancouver 3
Vilnius 3
Volta Redonda 3
Wilmington 3
Baghdad 2
Bangkok 2
Bari 2
Bogotá 2
Brasília 2
Brussels 2
Buenos Aires 2
Cachoeiro de Itapemirim 2
Calgary 2
Canoas 2
Cao Lanh 2
Caracas 2
Catanduva 2
Cochabamba 2
Concord 2
Da Nang 2
El Progreso 2
Ezeiza 2
Helena 2
Huelva 2
Jakarta 2
Kingston 2
Las Vegas 2
Lisbon 2
Lấp Vò 2
Milwaukee 2
Molise 2
Totale 2.517
Salva come PNG Salva come JPEG
Nome #
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 589
ELectrophysiological mechanisms underlying the Inhibitory CArdiac syncope without asystolic significant pause: Therapeutic and prognostic implications. The ELICA randomized trial 111
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study 105
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 103
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 102
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 94
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 91
Advances in Nanomedicine for Precision Insulin Delivery 91
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 89
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 82
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 81
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 80
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 79
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 79
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 77
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 77
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 74
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 74
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 73
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 72
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 68
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 66
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 64
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 63
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 63
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 61
Cardiovascular benefits from gliflozins: Effects on endothelial function 60
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 55
Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity 54
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 53
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 52
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 51
MicroRNAs modulation and clinical outcomes at 1 year of follow-up in obese patients with pre-diabetes treated with metformin vs. placebo 50
Role of subcutaneous abdominal fat on cardiac function and proinflammatory cytokines in premenopausal obese women 48
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 46
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 46
Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19 46
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 43
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 43
Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients 41
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 40
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 39
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 39
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 37
Metformin: An old drug against old age and associated morbidities 37
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 37
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 37
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 36
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 35
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 34
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 34
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up 33
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 32
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 32
Patients with adrenal insufficiency have cardiovascular features associated with hypovolemia 31
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 30
Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes 30
Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review 28
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 27
Metformin Lactic Acidosis: should we still be afraid? 27
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 26
Cardiovascular Therapeutics at the Crossroads: Pharmacological, Genetic, and Digital Frontiers 11
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study 9
Totale 4.017
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.469
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 2 0 1 0 2 0
2021/202210 0 2 0 0 0 0 2 1 1 2 0 2
2022/202347 5 1 0 3 2 2 0 3 25 1 5 0
2023/202493 3 2 2 2 4 15 3 7 1 5 5 44
2024/2025862 130 48 95 11 139 13 22 49 88 23 107 137
2025/20262.978 157 396 816 329 961 319 0 0 0 0 0 0
Totale 4.017